Role of Matrix Metalloproteinases in Subcapsular Cataract Formation

基质金属蛋白酶在囊下白内障形成中的作用

基本信息

  • 批准号:
    7825296
  • 负责人:
  • 金额:
    $ 20.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-03-01 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

The cytokine TGFP is a pleotropic morphogen that modulates the tissue repair phenotype and also plays an important role in the development of fibrotic repair pathologies. In the lens of the eye, fibrotic pathologies mediated by TGFP include anterior subcapsular cataracts (ASC) and posterior capsular opacification (PCO). The cellular changes that precede fibrosis in ASC and PCO include an increased proliferation of lens epithelial cells (LECs), which under go an epithelial-mesenchymal transformation (EMT) into myofibroblasts, involving loss of E-cadherin and induced a-smooth muscle actin (aSMA) expression. The long-term goal of this project is to determine the TGFp-mediated signals, which alter the genetic makeup and phenotype of lens epithelial cells during ASC. Using a previously developed rat lens culture model in which exogenous TGFP induces ASC we have shown that treatment with agents that inhibit enzymatic activity of Matrix Metalloproteinase (MMP) family members (MMPIs) suppresses the TGFp-induced cataractous changes. Further preliminary findings suggest the testable hypothesis that MMPIs act to inhibit TGFP- induced EMT and ASC in the lens by suppressing MMP-mediated E-cadherin degradation by shedding. The RSmad, SmadS, is a common effector of TGFP signaling, which has been identified in the lens. However, we have found using two different mouse models that in the absence of SmadS (in Smad3 KO mice) TGFpl can induce EMT in the lens, demonstrating the involvement of SmadS-independent signaling in ASC formation. Additional findings suggest that the hypothesis that TGFp-induced ASC involves signaling MAP kinase pathways, specifically p38,which act independently of Smad3. To test these hypotheses we will utilize the in vitro TGFp-induced rat lens model of ASC, as well as, genetically modified mice, including MMP-2, MMP-9 and SmadS KO mice. The effect of MMPIs on E-cadherin expression and shedding will be further examined using RT-QPCR in combination with laser capture microdissection, western blotting and immunolocalization. The requirement for activated pSSMAPKin ASC formation will be investigated in both the in vivo and in vitro models using specific Pp38 kinase inhibitors. These data will aid in defining the TGFp-mediated pathways controlling EMT and fibrosis in ASC. Furthermore, since the genes and signaling mechanisms in ASC formation are similar to those, which occur, in other fibrotic diseases and cancer, the information gained from these studies in the lens, may also have relevance to these disease entities.
细胞因子TGFP是一种多效性形态因子,可调节组织修复表型,并在组织修复中发挥重要作用

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Judith A West-Mays其他文献

Judith A West-Mays的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Judith A West-Mays', 18)}}的其他基金

Role of transcription factor activating protein-2 beta (AP-2β) in corneal epithelial cell fate determination and stratification
转录因子激活蛋白 2 beta (AP-2β) 在角膜上皮细胞命运决定和分层中的作用
  • 批准号:
    10510823
  • 财政年份:
    2022
  • 资助金额:
    $ 20.76万
  • 项目类别:
Role of transcription factor activating protein-2 beta (AP-2β) in corneal epithelial cell fate determination and stratification
转录因子激活蛋白 2 beta (AP-2β) 在角膜上皮细胞命运决定和分层中的作用
  • 批准号:
    10683400
  • 财政年份:
    2022
  • 资助金额:
    $ 20.76万
  • 项目类别:
Role of MMPs in TGFbeta-induced Cataract Formation
MMPs 在 TGFbeta 诱导的白内障形成中的作用
  • 批准号:
    8716760
  • 财政年份:
    2006
  • 资助金额:
    $ 20.76万
  • 项目类别:
Role of Matrix Metalloproteinases in Subcapsular Cataract Formation
基质金属蛋白酶在囊下白内障形成中的作用
  • 批准号:
    7589653
  • 财政年份:
    2006
  • 资助金额:
    $ 20.76万
  • 项目类别:
Role of Matrix Metalloproteinases in Subcapsular Cataract Formation
基质金属蛋白酶在囊下白内障形成中的作用
  • 批准号:
    7024380
  • 财政年份:
    2006
  • 资助金额:
    $ 20.76万
  • 项目类别:
Role of MMPs in TGFbeta-induced Cataract Formation
MMPs 在 TGFbeta 诱导的白内障形成中的作用
  • 批准号:
    8323802
  • 财政年份:
    2006
  • 资助金额:
    $ 20.76万
  • 项目类别:
Role of MMPs in TGFbeta-induced Cataract Formation
MMPs 在 TGFbeta 诱导的白内障形成中的作用
  • 批准号:
    8526365
  • 财政年份:
    2006
  • 资助金额:
    $ 20.76万
  • 项目类别:
Role of Matrix Metalloproteinases in Subcapsular Cataract Formation
基质金属蛋白酶在囊下白内障形成中的作用
  • 批准号:
    7186673
  • 财政年份:
    2006
  • 资助金额:
    $ 20.76万
  • 项目类别:
Role of MMPs in TGFbeta-induced Cataract Formation
MMPs 在 TGFbeta 诱导的白内障形成中的作用
  • 批准号:
    8188198
  • 财政年份:
    2006
  • 资助金额:
    $ 20.76万
  • 项目类别:
Role of Matrix Metalloproteinases in Subcapsular Cataract Formation
基质金属蛋白酶在囊下白内障形成中的作用
  • 批准号:
    7386538
  • 财政年份:
    2006
  • 资助金额:
    $ 20.76万
  • 项目类别:

相似海外基金

Development of a tele-mentoring system integrated into an ultra-portable surgical microscope to treat cataract in underserved populations
开发集成到超便携式手术显微镜中的远程指导系统,以治疗服务不足人群的白内障
  • 批准号:
    10602749
  • 财政年份:
    2023
  • 资助金额:
    $ 20.76万
  • 项目类别:
Improving Outcomes in Cataract Surgery: Intraocular Lenses (IOLs) Resistant to Cell Growth
改善白内障手术的效果:抗细胞生长的人工晶状体 (IOL)
  • 批准号:
    10841859
  • 财政年份:
    2023
  • 资助金额:
    $ 20.76万
  • 项目类别:
Role of the S100 Family of Proteins in Lens Physiology and Cataract
S100 蛋白家族在晶状体生理学和白内障中的作用
  • 批准号:
    10560827
  • 财政年份:
    2023
  • 资助金额:
    $ 20.76万
  • 项目类别:
Probing the specific interactions of AlphaA- crystallin and its aging- and cataract-associated forms with lens cell membrane mimics
探讨 AlphaA-晶状体蛋白及其与衰老和白内障相关的形式与晶状体细胞膜模拟物的特定相互作用
  • 批准号:
    10667060
  • 财政年份:
    2023
  • 资助金额:
    $ 20.76万
  • 项目类别:
Improving Outcomes in Cataract Surgery: Intraocular Lenses (IOLs) Resistant to Cell Growth
改善白内障手术的效果:抗细胞生长的人工晶状体 (IOL)
  • 批准号:
    10573497
  • 财政年份:
    2023
  • 资助金额:
    $ 20.76万
  • 项目类别:
Planning for an international symposium on patient/physician shared decision making for cataract surgery appropriateness and prioritization
规划举办关于患者/医生共同决策白内障手术适当性和优先顺序的国际研讨会
  • 批准号:
    461048
  • 财政年份:
    2022
  • 资助金额:
    $ 20.76万
  • 项目类别:
    Miscellaneous Programs
Using Informatics to Evaluate and Predict Cataract Surgery Impact on Alzheimer's Disease and Related Dementias and Mild Cognitive Impairment Outcomes
利用信息学评估和预测白内障手术对阿尔茨海默病和相关痴呆症以及轻度认知障碍结果的影响
  • 批准号:
    10688255
  • 财政年份:
    2022
  • 资助金额:
    $ 20.76万
  • 项目类别:
Lens capsule and secondary cataract
晶状体囊和继发性白内障
  • 批准号:
    10706997
  • 财政年份:
    2022
  • 资助金额:
    $ 20.76万
  • 项目类别:
Lens capsule and secondary cataract
晶状体囊和继发性白内障
  • 批准号:
    10433474
  • 财政年份:
    2022
  • 资助金额:
    $ 20.76万
  • 项目类别:
Using Informatics to Evaluate and Predict Cataract Surgery Impact on Alzheimer's Disease and Related Dementias and Mild Cognitive Impairment Outcomes
利用信息学评估和预测白内障手术对阿尔茨海默病和相关痴呆症以及轻度认知障碍结果的影响
  • 批准号:
    10525214
  • 财政年份:
    2022
  • 资助金额:
    $ 20.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了